Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antipneumococcal vaccination: comparison between vaccines].

M G Galli, G M Fara

    Bollettino Dell'Istituto Sieroterapico Milanese
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Erice 58 Charter on 'The health of migrants. An equity challenge for the public health system'.

    Annali di igiene : medicina preventiva e di comunita·2023
    Same author

    Ausilia Maria Lucia (Lia) Pulimeno, to whom the Nursing and the Healthcare Worlds owe a lot.

    Annali di igiene : medicina preventiva e di comunita·2022
    Same author

    Celebrating Public Health lives.

    Annali di igiene : medicina preventiva e di comunita·2020
    Same author

    Impact of the environment on the health: From theory to practice.

    Environmental research·2020
    Same author

    Effectiveness of face masks for the population.

    Annali di igiene : medicina preventiva e di comunita·2020
    Same author

    Face masks. Technical, technological and functional characteristics and hygienic-sanitary aspects related to the use of filtering mask in the community.

    Annali di igiene : medicina preventiva e di comunita·2020

    This study evaluated polyvalent vaccines against Streptococcus pneumoniae in healthy volunteers. The 17-valent vaccine demonstrated superior antibody response across more antigens compared to the 14-valent vaccine, suggesting its potential for broader pneumococcal disease prevention.

    Area of Science:

    • Immunology
    • Vaccinology
    • Microbiology

    Background:

    • Streptococcus pneumoniae causes significant global disease burden.
    • Development of effective polyvalent vaccines is crucial for prevention.
    • Assessing immunogenicity and safety of novel vaccine formulations is essential.

    Purpose of the Study:

    • To compare the immunogenicity and safety of a 14-valent and a 17-valent polyvalent pneumococcal vaccine.
    • To evaluate the antibody response against multiple Streptococcus pneumoniae serotypes.
    • To assess the suitability of these vaccines for high-risk populations.

    Main Methods:

    • A randomized controlled trial involving 137 healthy volunteers.
    • Administration of either a 14-valent or 17-valent polyvalent pneumococcal vaccine.

    Related Experiment Videos

  • Antibody concentration measured by radioimmunoassay (RIA) to determine immune response.

    • Main Results:

    • Both vaccines were infrequently associated with side effects.
    • The 17-valent vaccine elicited a two-fold or higher antibody increase in 80% of vaccinees against all antigens.
    • The 14-valent vaccine showed a similar response for 12 out of 14 antigens, with lower percentages for antigens 1 and 12F.

    Conclusions:

    • The 17-valent pneumococcal vaccine demonstrates broader immunogenicity compared to the 14-valent vaccine.
    • Both vaccines are well-tolerated with infrequent side effects.
    • These vaccines are recommended for preventing pneumococcal diseases, especially in high-risk individuals.